Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions
Generated Narrative: Composition
Resource Composition "composition-drug-pq-risk"
Profile: Composition - Drug PQ
status: final
type: Product Note - Summary for Risk of Impurities ()
date: 2023-10-01
author: Organization/organization-drug-pq-ex1 "AAA Molybdenum Products, Inc."
title: 3.2.P.2.2.4 - Summary for Risk of Impurities